This trial is assessing the prevalence of two liver diseases, Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and assembling a cohort of adults with these diseases to better understand them.
1 Primary · 1 Secondary · Reporting Duration: 5 years
800 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: